ABSIAbsci Corpvs its industry peers
A metric-by-metric comparison of Absci Corp against Services-Commercial Physical & Biological Research — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ABSIThis | $1.5B#5 | — | 6.1x#9 | 539.4x#15 | -38.2%#14 | -11.7%#11 | -4297.0%#15 | -46.8%#9 | -84.6%#5 | — | 269.7%#1 | — |
| IQV | $44.1B#1 | 32.8x#4 | 7.1x#10 | 2.7x#5 | 5.9%#6 | -0.9%#7 | 13.4%#4 | 21.9%#4 | 9.1%#3 | — | 45.0%#7 | 1.3%#2 |
| INCY | $25.7B#2 | 18.2x#3 | 4.6x#7 | 5.0x#9 | 21.2%#4 | 3846.9%#1 | 29.5%#1 | 22.9%#3 | 49.0%#1 | — | 48.2%#6 | — |
| MEDP | $16.5B#3 | 34.8x#5 | 38.1x#12 | 6.5x#11 | 20.0%#5 | 11.6%#5 | 21.1%#2 | 104.0%#2 | — | — | 23.2%#9 | — |
| CRL | $13.9B#4 | — | 4.9x#8 | 3.5x#7 | -0.9%#7 | -750.1%#16 | 0.6%#5 | -5.1%#5 | 0.6%#4 | — | 79.7%#5 | — |
| OABI | $733M#6 | — | 2.8x#6 | 39.3x#14 | -29.3%#10 | -4.4%#8 | -369.5%#10 | -24.9%#6 | — | — | 231.6%#2 | — |
| NRC | $442M#7 | 0.4x#2 | 67.5x#13 | 3.2x#6 | -4.0%#8 | -53.2%#12 | 16.4%#3 | 177.1%#1 | 15.7%#2 | — | 39.0%#8 | 2.5%#1 |
| MXCT | $132M#8 | — | 0.8x#3 | 6.3x#10 | -5.7%#9 | -8.7%#10 | -247.6%#9 | -28.1%#8 | — | — | -7.6%#11 | — |
| BIAF | $79M#9 | — | 21.1x#11 | 12.9x#12 | -34.2%#12 | -64.9%#13 | -171.6%#7 | -395.6%#10 | -661.2%#8 | — | -90.7%#13 | — |
| ONMD | $34M#10 | — | — | 25.0x#13 | 111.4%#2 | 72.3%#2 | -711.3%#13 | — | — | 4#1 | -35.0%#12 | — |
| OABIW | $33M#11 | — | 0.1x#1 | 1.8x#3 | -29.3%#10 | -4.4%#8 | -369.5%#10 | -24.9%#6 | — | — | -3.2%#10 | — |
| ONMDW | $6M#12 | — | — | 4.6x#8 | 111.4%#2 | 72.3%#2 | -711.3%#13 | — | — | 4#1 | 126.5%#3 | — |
| BIAFW | $4M#13 | — | 1.0x#4 | 0.6x#2 | -34.2%#12 | -64.9%#13 | -171.6%#7 | -395.6%#10 | -661.2%#8 | — | 95.8%#4 | — |
| ISPC | $4M#14 | 0.0x#1 | 2.2x#5 | 2.0x#4 | -79.2%#15 | 16.1%#4 | -465.4%#12 | -604.0%#12 | -511.9%#7 | — | -94.4%#14 | — |
| FOXO | $150889#15 | — | 0.2x#2 | 0.0x#1 | 304.0%#1 | -0.2%#6 | -63.1%#6 | -1257.7%#13 | -268.4%#6 | — | -100.0%#15 | — |
| BUDZ | — | — | — | — | — | -168.7%#15 | — | — | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 8731). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-09-03.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice